H. Buller

发表

Diagnostic strategies for the management of patients with clinically suspected deep‐vein thrombosis

J. Lijmer, M. Prins, P. Prandoni, 1997, Current opinion in pulmonary medicine.

Accuracy of clinical decision rule, D‐dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism

H. Büller, L. Tick, M. Kruip, 2006, Journal of thrombosis and haemostasis : JTH.

Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism.

M. Prins, H. Büller, A. Lensing, 1998, Current opinion in pulmonary medicine.

Treatment of venous thromboembolism

S. Middeldorp, M. Sohne, H. Buller, 2005, Journal of thrombosis and haemostasis : JTH.

Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial

G. Raskob, H. Büller, G. Agnelli, 2015, Journal of thrombosis and haemostasis : JTH.

University of Birmingham Atherothrombosis and Thromboembolism :

T. Renné, H. Crijns, N. Mackman, 2018 .

Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? A historic follow-up study in primary care.

G. ter Riet, G. Dolan, H. V. van Weert, 2006, The Journal of family practice.

Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK.

A. Nicolaides, J. Arcelus, D. Bergqvist, 1992, International angiology : a journal of the International Union of Angiology.

Is contrast venography a valid surrogate outcome measure in venous thromboembolism prevention studies?

M. Prins, A. Lensing, A. Segers, 2005, Journal of thrombosis and haemostasis : JTH.

Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets

J. T. ten Cate, H. Buller, P. Treffers, 1991 .

Thromboprophylaxis in hip fracture surgery: a pilot study comparing danaparoid, enoxaparin and dalteparin. The TIFDED Study Group.

D. Bergqvist, H. Buller, F. Bachman, 1999, Haemostasis.

PROTHROMBIN 20210 G: A MUTATION AND FACTOR V LEIDEN MUTATION IN WOMEN WITH A HISTORY OF SEVERE PREECLAMPSIA AND (H)ELLP SYNDROME*

P. Reitsma, H. Buller, H. Wolf, 2001, Hypertension in pregnancy.

Cancer and thrombosis: from molecular mechanisms to clinical presentations

H. Büller, P. Kamphuisen, H. Buller, 2007, Journal of thrombosis and haemostasis : JTH.

Mortality in hereditary antithrombin-III deficiency—1830 to 1989

D. Hommes, F. Rosendaal, H. Buller, 1991, The Lancet.

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis

H. Crijns, U. Schotten, T. Renné, 2018, Thrombosis and Haemostasis.

Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis‐Atrial Fibrillation Study

G. Raskob, G. Hankey, J. Halperin, 2014, Journal of thrombosis and haemostasis : JTH.

Factor VIII deficiency does not protect against atherosclerosis

H. Büller, E. Groot, P. Verhamme, 2012, Journal of thrombosis and haemostasis : JTH.

Intravascular coagulation in surgery for large acoustic neuromas.

J. Van Der Sande, H. Buller, 1987, Journal of neurology, neurosurgery, and psychiatry.

SILENT PULMONARY EMBOLISM IN PATIENTS WITH DEEP VEIN THROMBOSIS

J. T. ten Cate, J. Vreeken, M. Huisman, 1987, Thrombosis and Haemostasis.

Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia.

H. Radford, S. Louw, B. Brenner, 2021, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis

C. Bradbury, P. Prandoni, B. Hutton, 2021, Thrombosis and Haemostasis.

The incidence of venous thromboembolism in asymptomatic carriers of antithrombin, protein C or protein S: a prospective cohort study.

P. Prandoni, M. Moia, P. Wells, 1999 .

Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways

H. Büller, S. Deventer, C. Hack, 1990 .

Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery

H. Büller, J. T. ten Cate, M. Gent, 1996, Thrombosis and Haemostasis.

The Effects of Aspirin and Clopidogrel Response on Myonecrosis After Percutaneous Coronary Intervention

D. Ricci, S. Walsh, G. Wong, 2008 .

Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.

P. Serruys, H. Suryapranata, J. Deckers, 1993, Circulation.

Coagulation and platelet activation pathways. A review of the key components and the way in which these can be manipulated.

T. ten Cate, H. Büller, H. Buller, 1995, European heart journal.